{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:00:26Z","timestamp":1793012426227,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.yexcr.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:44:04Z","timestamp":1533559444000},"page":"175-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro"],"prefix":"10.1016","volume":"371","author":[{"given":"Maria","family":"Eriksdotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Navarro-Oviedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6381-5344","authenticated-orcid":false,"given":"Sumonto","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wahlberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Linderoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars O.","family":"Tjernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homira","family":"Behbahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2018.08.007_bib1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Clinical trial, two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2018.08.007_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00248282","article-title":"NGF treatment promotes development of basal forebrain tissue grafts in the anterior chamber of the eye","volume":"74","author":"Eriksdotter-Nilsson","year":"1989","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0197-4580(89)80014-4","article-title":"Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease","volume":"10","author":"Hefti","year":"1989","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.yexcr.2018.08.007_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pneurobio.2006.09.001","article-title":"Nerve growth factor in treatment and pathogenesis of Alzheimer's disease","volume":"80","author":"Williams","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer's disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.yexcr.2018.08.007_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/156720509787602870","article-title":"Development of a non invasive NGF-based therapy for Alzheimer's disease","volume":"6","author":"Covaceuszach","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2018.08.007_bib9","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3727\/096368912X638964","article-title":"Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction","volume":"21","author":"Lee","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.yexcr.2018.08.007_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease","volume":"9","author":"Eriksdotter Jonhagen","year":"1998","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.yexcr.2018.08.007_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02257624","article-title":"Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report)","volume":"4","author":"Olson","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.yexcr.2018.08.007_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2015.05.003","article-title":"Cell encapsulation: technical and clinical advances","volume":"36","author":"Orive","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.yexcr.2018.08.007_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000336051","article-title":"Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease","volume":"33","author":"Eriksdotter-Jonhagen","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.yexcr.2018.08.007_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3171\/2012.2.JNS11714","article-title":"Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery","volume":"117","author":"Wahlberg","year":"2012","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.yexcr.2018.08.007_bib15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3233\/JAD-141068","article-title":"Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor","volume":"43","author":"Ferreira","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.yexcr.2018.08.007_bib16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jalz.2014.11.008","article-title":"Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease","volume":"11","author":"Karami","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.yexcr.2018.08.007_bib17","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/mt.2010.154","article-title":"Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Gottingen minipig basal forebrain","volume":"18","author":"Fjord-Larsen","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2018.08.007_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.yexcr.2018.08.007_bib19","article-title":"Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia","volume":"2010","author":"Hjorth","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.yexcr.2018.08.007_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jnr.20634","article-title":"Flow cytometry as a method for studying effects of stressors on primary rat neurons","volume":"82","author":"Behbahani","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib21","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00213-013-3378-0","volume":"231","author":"Fukumoto","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.yexcr.2018.08.007_bib22","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1582-4934.2011.01441.x","article-title":"Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease","volume":"16","author":"Hashimoto","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yexcr.2018.08.007_bib23","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1002\/pmic.201400211","article-title":"Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice","volume":"15","author":"Nilsson","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.yexcr.2018.08.007_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1074\/mcp.T500021-MCP200","article-title":"Automated comparative proteomics based on multiplex tandem mass spectrometry and stable isotope labeling","volume":"5","author":"Zhang","year":"2006","journal-title":"Mol. Cell. Proteom."},{"issue":"2016","key":"10.1016\/j.yexcr.2018.08.007_bib25","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"update of the PRIDE database and its related tools","volume":"44","author":"Vizcaino","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10495-007-0756-2","article-title":"Mitochondria, oxidative stress and cell death","volume":"12","author":"Ott","year":"2007","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2018.08.007_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2006-9202","article-title":"The key role of mitochondria in Alzheimer's disease","volume":"9","author":"Moreira","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.yexcr.2018.08.007_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2016.01.008","article-title":"Alzheimer's disease: an overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products","volume":"361","author":"Awasthi","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.yexcr.2018.08.007_bib29","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1016\/j.febslet.2006.10.061","article-title":"IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?","volume":"580","author":"Perrier","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2018.08.007_bib30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/gt.2011.178","article-title":"Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer","volume":"19","author":"Fjord-Larsen","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2018.08.007_bib31","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1128\/MCB.01955-08","article-title":"Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation","volume":"29","author":"Swat","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib32","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1523\/JNEUROSCI.0183-10.2010","article-title":"Transfection techniques for neuronal cells","volume":"30","author":"Karra","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.yexcr.2018.08.007_bib33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000334644","article-title":"Cerebrospinal fluid Alzheimer markers in depressed elderly subjects with and without Alzheimer's disease","volume":"2","author":"Kramberger","year":"2012","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.yexcr.2018.08.007_bib34","first-page":"663","article-title":"Staurosporine induces apoptosis in NG108-15 cells","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.yexcr.2018.08.007_bib35","doi-asserted-by":"crossref","first-page":"e55847","DOI":"10.1371\/journal.pone.0055847","article-title":"The pathogenic abeta43 is enriched in familial and sporadic Alzheimer disease","volume":"8","author":"Sandebring","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2018.08.007_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1742-2094-10-59","article-title":"Acute and subacute IL-1beta administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration","volume":"10","author":"Song","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.yexcr.2018.08.007_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jnr.20735","article-title":"Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity","volume":"83","author":"Patel","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jbm.820250906","article-title":"Mast cells and tissue reaction to intraperitoneally implanted polymer capsules","volume":"25","author":"Christenson","year":"1991","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib39","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/193229680800200628","article-title":"Anti-inflammatory polymeric coatings for implantable biomaterials and devices","volume":"2","author":"Bridges","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2007.02.024","article-title":"Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes","volume":"1148","author":"Zhong","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.yexcr.2018.08.007_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib42","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/ajp.151.8.1105","article-title":"Inflammatory mechanisms in Alzheimer's disease: implications for therapy","volume":"151","author":"Aisen","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.yexcr.2018.08.007_bib43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410280414","article-title":"Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia","volume":"28","author":"Matsubara","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archneur.1985.04210090039011","article-title":"Alpha 1-antitrypsin in cerebrospinal fluid of patients with neurologic diseases","volume":"42","author":"Pearl","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib45","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1212\/01.wnl.0000271077.82508.a0","article-title":"and CSF serpins in Alzheimer disease and dementia with Lewy bodies","volume":"69","author":"Nielsen","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yexcr.2018.08.007_bib46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-150036","article-title":"Clusterin levels in plasma predict cognitive decline and progression to Alzheimer's disease","volume":"46","author":"Jongbloed","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.yexcr.2018.08.007_bib47","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1074\/jbc.M115.689539","article-title":"Clusterin binds to Abeta1-42 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation","volume":"291","author":"Beeg","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2018.08.007_bib48","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1291","article-title":"Clusterin inhibits apoptosis by interacting with activated Bax","volume":"7","author":"Zhang","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib49","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1189\/jlb.0311110","article-title":"Clusterin induces matrix metalloproteinase-9 expression via ERK1\/2 and PI3K\/Akt\/NF-kappaB pathways in monocytes\/macrophages","volume":"90","author":"Shim","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2018.08.007_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","article-title":"ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo","volume":"41","author":"DeMattos","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.yexcr.2018.08.007_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-394317-0.00011-X","article-title":"Clusterin in Alzheimer's disease","volume":"56","author":"Wu","year":"2012","journal-title":"Adv. Clin. Chem."},{"issue":"Pt 3","key":"10.1016\/j.yexcr.2018.08.007_bib52","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/bj3390759","article-title":"Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells","volume":"339","author":"Gutacker","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2018.08.007_bib53","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0047-6374(01)00311-6","article-title":"Activation of complement and contact system in Alzheimer's disease","volume":"122","author":"Bergamaschini","year":"2001","journal-title":"Mech. Ageing Dev."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271830658X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271830658X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:15:32Z","timestamp":1762146932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448271830658X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S001448271830658X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.08.007","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}